An underactive thyroid can add modest weight and fatigue, so a TSH test is a sensible check if you have symptoms. Separately, GLP-1 labels warn against use with a personal or family history of medullary thyroid cancer or MEN 2, so share your full thyroid history.
Thyroid health matters before a GLP-1 program for two separate reasons. First, an underactive thyroid (hypothyroidism) can cause fatigue and some weight gain, so it is worth ruling out or treating when symptoms point that way. Second, the labels for semaglutide and tirzepatide carry a boxed warning about a specific, rare thyroid cancer, so your prescriber needs to know about any personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Common conditions such as treated hypothyroidism are a different matter from that warning.
The thyroid is a small, butterfly-shaped gland in the front of the neck. Its hormones help control how the body uses energy, which is why they affect nearly every organ. The American Thyroid Association (ATA) explains that high thyroid hormone levels raise resting metabolic rate and low levels reduce it, though many other hormones and factors also influence weight.
According to the ATA:
The practical message is that thyroid problems are worth finding and treating, but they rarely explain large or long-standing weight changes on their own. If other hypothyroid symptoms improve with treatment and the weight does not, the ATA notes it is unlikely the weight was only due to the thyroid.
The NIDDK estimates that nearly 5 out of 100 Americans ages 12 and older have hypothyroidism, though most cases are mild. Women are much more likely than men to develop it, and it is more common after age 60. Hashimoto's disease, an autoimmune condition, is the most common cause.
NIDDK also lists factors that raise the likelihood, including:
Common symptoms include fatigue, weight gain, feeling cold, joint and muscle pain, dry skin or thinning hair, heavy or irregular periods, a slowed heart rate and depression. Because hypothyroidism develops slowly, symptoms may go unnoticed for months or even years.
MedlinePlus describes the TSH (thyroid-stimulating hormone) test as a simple blood test that measures a hormone made by the pituitary gland. When thyroid hormone levels are low, the pituitary makes more TSH to push the thyroid harder; when levels are high, TSH drops. A TSH result that is too high or too low may point to a thyroid problem, and abnormal results usually lead to additional tests.
A few tips for getting an accurate result:
Thyroid testing is one part of a broader pre-treatment picture. Our guide to reading your metabolic labs covers A1c, lipids, liver enzymes and kidney function.
Both the Wegovy (semaglutide) and Zepbound (tirzepatide) labels carry a boxed warning about thyroid C-cell tumors. In plain language:
| Your thyroid history | Why it matters before a GLP-1 program |
|---|---|
| Personal or family history of MTC, or MEN 2 | Semaglutide and tirzepatide labels list this as a contraindication |
| Underactive thyroid, treated | Not the subject of the boxed warning; keep thyroid levels monitored |
| Overactive thyroid | Can itself change weight and appetite; worth evaluating and treating |
| Other thyroid cancer, nodules or surgery | Share the details so your prescriber can review them against the label |
If you are not sure what type of thyroid cancer a relative had, it is worth finding out before you start, because the label warning is specific to MTC.
Two points are worth knowing.
Thyroid hormone is not a weight-loss tool. The Synthroid label's boxed warning states that thyroid hormones should not be used to treat obesity or for weight loss, that amounts within normal hormone needs are ineffective for weight reduction in people with normal thyroid function, and that larger amounts may cause serious or even life-threatening toxicity. The ATA adds that excess thyroid hormone can cause insomnia, palpitations, anxiety, muscle and bone loss and heart rhythm problems, and that weight lost this way usually returns once it is stopped.
GLP-1 medications can affect how oral medicines are absorbed. The Wegovy label explains that semaglutide slows stomach emptying, which may affect absorption of other oral medications. In a study with the Wegovy tablet, levothyroxine exposure increased by 33 percent. Your clinician may decide to recheck your thyroid levels after you start, and any change to your thyroid prescription is a decision for the prescriber.
An underactive thyroid is not the condition named in the GLP-1 boxed warning, which concerns MTC and MEN 2. Your prescriber will review your full history and may monitor your thyroid levels during treatment.
Semaglutide and tirzepatide caused thyroid C-cell tumors in rodents, and it is not known whether this happens in humans. Because of that uncertainty, the labels say not to use them if you or a family member has had MTC or if you have MEN 2. Report any new neck lump, trouble swallowing or persistent hoarseness to your clinician.
If you have symptoms such as fatigue, feeling cold, dry skin or irregular periods, or risk factors such as a family history of thyroid disease, a TSH test is a reasonable step. Your licensed provider will decide which labs are appropriate based on your history.
Not in people with normal thyroid function. The levothyroxine label specifically warns against using thyroid hormone for obesity or weight loss because normal amounts do not reduce weight and larger amounts can be dangerous. If you have hypothyroidism, treatment aims to restore normal levels, which the ATA says generally returns weight to where it was before the condition began.
Before starting a GLP-1 program, tell your licensed provider about any thyroid condition, thyroid surgery, neck radiation, family history of thyroid cancer or MEN 2, and every medication and supplement you take. They can decide whether thyroid testing is needed and how to monitor you during treatment. This article is educational and does not determine eligibility for any treatment.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
GLP-1 results vary widely. In trials, most people reached at least 5 percent weight loss while a minority did not. Medication and dose, type 2 diabetes, staying on treatment and early response all help explain the spread.
Read article
You can travel, celebrate and eat out on a GLP-1 medication with some planning: keep medication in your carry-on and follow your pharmacy's storage instructions, order smaller portions, keep fluids up, and ask your prescriber how to handle timing changes.
Read articlePeople switch GLP-1 medications because of side effects, response, cost or access. There is no universal conversion chart, the labels advise against combining these drugs, and your prescriber sets the new starting point. Here are the questions worth asking.
Read article